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scores”, each clustering a deﬁned set of questions. RESULTS:
(2002 ﬁgures in brackets): Samples did not differ signiﬁcantly in
structure. The 16 practices recruited n = 1639 patients (n =
1826), 50.9% women (55.0); mean age 63.6 years (62.4). Com-
paring 2004 with 2002 it is demonstrated that 5 practices
showed overall improvement in all dimensions, 3 practices
improved in some, 4 practices improved and decreased, while 4
maintained steady state. Patients of one practice reported much
more problems in all dimensions in 2002 than on average. In
2004, the practice presents with only “praxis organisation”
being still an issue for patients (+37%). This practice demon-
strated an overall better performance based on improvements in
8 out of 13 scales. Problem scores dropped (i.e. improvement)
especially interpersonal communication dimensions, i.e. patient-
physician relationship (-56%), co-management (-32%),
involvement of family members (-54%), discussion with other
patients (-41%). CONCLUSION: Assessing patient satisfaction
over time is one tool to generate a platform for quality assur-
ance in oncological care. The PASCOQ® questionnaire is a tool
to assess not only status quo but is also feasible to detect changes
in patients’ satisfaction with physicians, staff, environment as
well as side effects and supportive medication.
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OBJECTIVES: To assess the estimated prevalence of possible
ﬁbromyalgia sufferers among the general adults population in
Portugal using a screening questionnaire, the LFES-SQ developed
by White. METHODS: This questionnaire was administrated to
a random community sample of 500 persons interviewed by tele-
phone and positive responders to the screening questionnaire
were classiﬁed as “pain sufferers”. Using a sample of patients
coming to Rheumatologist departments we administrated to
them the same screening questionnaire and we diagnosed this
entire sample to see if they were ﬁbromyalgia sufferers (using the
1990 ACR criteria). Once we had calculated the ratio between
patients “positive” to the screening questionnaire and the
number of patients really diagnosed with ﬁbromyalgia, we
applied this ratio to our population of “pain sufferers” and
therefore obtain an estimate of the prevalence of possible
ﬁbromyalgia sufferers. It is important to note that we worked 
on two different populations. RESULTS: In Portugal following
the hospital survey the results were the following: 225 inter-
viewed patients (191 women, 34 men) among them 154 were
screened positive (136 and 18) and 51 cases of ﬁbromyalgia (50
and 1) therefore multiplication factors of possible ﬁbromyalgia
patients VS number of positive = Total ﬁbromyalgia cases in
Lisboa / Number of Patients screened positive i.e. . . . multipli-
cation factor for the total population = 51/154 = 0.331; for
women = 50/136 = 0.368 and for men = 1/18 = 0.056. Once
those ratio were applied to our random community representa-
tive sample of 500 persons we obtained the following: an esti-
mated prevalence of FMS in Portugal of 6.09% of the total
population, 8.76% of women and 0.69% of men. CONCLU-
SION: Those data are higher than the ones obtained in the White
study or in the published prevalence of ﬁbromyalgia in the liter-
ature, but they allow us to assess an estimated prevalence of
ﬁbromyalgia.
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OBJECTIVE: To assess the estimated prevalence of possible
Fibromyalgia (FM) sufferers among the general adults popula-
tion in Italy using the LFES-SQ, a screening questionnaire 
developed by White. METHODS: This questionnaire was
administrated to a random community sample of 1000 persons
interviewed by telephone and positive responders to the screen-
ing questionnaire were classiﬁed as “pain sufferers”. Using a
ratio calculated in Portugal between patients “positive” (+) to
the screening questionnaire and the number of patients really
diagnosed with FMS, we applied this ratio to our population of
“pain sufferers” and therefore obtain an estimate of the preva-
lence of possible ﬁbromyalgia sufferers in Italy, please note that
we worked on two different populations. The ratio was calcu-
lated using a sample of patients in Lisboa, to whom we admin-
istrated the same screening questionnaire and we diagnosed this
entire sample to see if they were FMS sufferers (using the 1990
ACR criteria). RESULTS: In Portugal following the hospital
survey we were able to calculate the following ratios: Multipli-
cation factors of possible FMS patients VS number of (+) = Total
FM cases in Lisboa / Number of Patients screened (+), i.e. . . .
multiplication factor for the total population = 51/154 = 0.331;
multiplication factor for women = 50/136 = 0.368; multiplica-
tion factor for men = 1/18 = 0.056. Once those ratio were applied
to our random sample of 1000 persons we obtained an estimated
prevalence of FMS in Italy of 4.17% of the total population,
6.99% of women and 0.31% of men. CONCLUSION: Those
data are higher than those obtained in the White study or in the
published prevalence of FMS in the literature, but they allow us
to assess an estimated prevalence of FMS. The next steps will be
to calculate local multiplication factors of FMS in Italy in order
to improve those estimates and to generalise this survey in
Europe.
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OBJECTIVE: To compare the management of ﬁbromyalgia
amongst French and Portuguese General Practitioners (GPs).
METHODS: A questionnaire with a prepaid envelope was sent
to a sample of 10,000 GPs in France and to all practicing GPs
(n = 8399) in Portugal. This questionnaire was organized in six
main sections: the characteristics of the physician’s professional
practice, the physician’s opinion on ﬁbromyalgia, the main symp-
toms of ﬁbromyalgia, diagnosis criteria, treatments of ﬁbromyal-
gia, sources of knowledge on ﬁbromyalgia. RESULTS: A total of
1130 French GPs (response rate: 11.3%) and 337 Portuguese
GPs (response rate: 4%) returned the questionnaire. In France
66% are male with an average age of 47, whereas in Portugal
52% are male with an average age of 50. The proﬁle of the
respondents is similar in age and gender to the average national
proﬁle. Thirty-three percent of French GPs and 29.5% of the
Portuguese ones afﬁrm that ﬁbromyalgia is a disease; 63% and
68% respectively claim it is a symptom and it is only for 2% of
French and 2.5% of the Portuguese GPs that ﬁbromyalgia does
